Jul 1, 2024, 14:03
Robert Jotte presents how Adagrasib shows improvement in PFS and ORR in previously treated patients – Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn:
“Significant advancements in NSCLC treatment! SCRI’s Dr. Robert Jotte presents how Adagrasib shows improvement in PFS and ORR over Docetaxel in previously treated patients. Watch his detailed discussion on ecancer.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 16, 2024, 10:10
Nov 16, 2024, 10:08
Nov 16, 2024, 10:06
Nov 16, 2024, 10:02
Nov 16, 2024, 10:00
Nov 16, 2024, 09:57
Nov 16, 2024, 09:51
Nov 16, 2024, 09:44
Nov 16, 2024, 09:31